No Material Adverse Change; Financial Statements. All consolidated financial statements for Borrower and its consolidated Subsidiaries, delivered to Collateral Agent fairly present, in conformity with GAAP, and in all material respects the consolidated financial condition of Borrower and its consolidated Subsidiaries, and the consolidated results of operations of Borrower and its consolidated Subsidiaries. Since December 31, 2020, there has not been a Material Adverse Change.
Appears in 7 contracts
Samples: Loan and Security Agreement (Vapotherm Inc), Loan and Security Agreement (Vapotherm Inc), Loan and Security Agreement (Vapotherm Inc)
No Material Adverse Change; Financial Statements. All consolidated financial statements for Borrower and its consolidated Subsidiaries, delivered to Collateral Agent fairly present, in conformity with GAAP, and in all material respects the consolidated financial condition of Borrower and its consolidated Subsidiaries, and the consolidated results of operations of Borrower and its consolidated Subsidiaries. Since December 31, 2020the date of the most recent financial statements submitted to any Lender, there has not been a Material Adverse Change.
Appears in 5 contracts
Samples: Loan and Security Agreement (Celcuity Inc.), Loan and Security Agreement (Apollo Endosurgery, Inc.), Loan and Security Agreement (Celcuity Inc.)
No Material Adverse Change; Financial Statements. All consolidated financial statements for Borrower and its consolidated Subsidiaries, Subsidiaries delivered to Collateral Agent fairly present, in conformity with GAAP, GAAP and in all material respects respects, the consolidated financial condition of Borrower and its consolidated Subsidiaries, and the consolidated results of operations of Borrower and its consolidated Subsidiaries. Since December 31, 20202016, there has not been a Material Adverse Change.
Appears in 4 contracts
Samples: Loan and Security Agreement (Alimera Sciences Inc), Loan and Security Agreement (Alimera Sciences Inc), Loan and Security Agreement (Alimera Sciences Inc)
No Material Adverse Change; Financial Statements. All consolidated financial statements for Borrower and its consolidated Subsidiaries, delivered to Collateral Agent fairly present, in conformity with GAAP, and in all material respects the consolidated financial condition of Borrower and its consolidated Subsidiaries, and the consolidated results of operations of Borrower and its consolidated Subsidiaries. Since December 31, 20202017, there has not been a Material Adverse Change.
Appears in 4 contracts
Samples: Loan and Security Agreement (Cardiva Medical, Inc.), Loan and Security Agreement (GenMark Diagnostics, Inc.), Loan and Security Agreement (Ardelyx, Inc.)
No Material Adverse Change; Financial Statements. All consolidated financial statements for Borrower and its consolidated Subsidiaries, delivered to Collateral Agent fairly present, in conformity with GAAP, and in all material respects the consolidated financial condition of Borrower and its consolidated Subsidiaries, and the consolidated results of operations of Borrower and its consolidated Subsidiaries. Since December 31, 20202018, there has not been a Material Adverse Change.
Appears in 3 contracts
Samples: Loan and Security Agreement (Neuronetics, Inc.), Loan and Security Agreement (Neuronetics, Inc.), Loan and Security Agreement (Neuronetics, Inc.)
No Material Adverse Change; Financial Statements. All consolidated financial statements for Borrower and its consolidated Subsidiaries, delivered to Collateral Agent fairly present, in conformity with GAAP, and in all material respects the consolidated financial condition of Borrower and its consolidated Subsidiaries, and the consolidated results of operations of Borrower and its consolidated Subsidiaries. Since December 31, 2020the date of the most recent financial statements submitted to Collateral Agent and Innovatus, there has not been a Material Adverse Change.
Appears in 2 contracts
Samples: Loan and Security Agreement (Exagen Inc.), Loan and Security Agreement (Exagen Inc.)
No Material Adverse Change; Financial Statements. All consolidated financial statements for Borrower and its consolidated Subsidiaries, delivered to Collateral Agent fairly present, in conformity with GAAP, and in all material respects the consolidated financial condition of Borrower and its consolidated Subsidiaries, and the consolidated results of operations of Borrower and its consolidated Subsidiaries. Since December 31, 20202014, there has not been a Material Adverse Change.
Appears in 2 contracts
Samples: Loan and Security Agreement (Nanosphere Inc), Loan and Security Agreement (Imprimis Pharmaceuticals, Inc.)
No Material Adverse Change; Financial Statements. All consolidated financial statements for Borrower the Loan Parties and its consolidated Subsidiaries, delivered to Collateral Agent fairly present, in conformity with GAAP, and in all material respects the consolidated financial condition of Borrower the Loan Parties and its consolidated Subsidiaries, Subsidiaries and the consolidated results of operations of Borrower the Loan Parties and its consolidated SubsidiariesSubsidiaries as of and for the dates presented. Since December 31, 20202019, there has not been a Material Adverse Change.
Appears in 2 contracts
Samples: Loan and Security Agreement (Rapid Micro Biosystems, Inc.), Loan and Security Agreement (Rapid Micro Biosystems, Inc.)
No Material Adverse Change; Financial Statements. All consolidated financial statements for Borrower and its consolidated Subsidiaries, Subsidiaries delivered to Collateral Agent fairly present, in conformity with GAAP, GAAP and in all material respects respects, the consolidated financial condition of Borrower and its consolidated Subsidiaries, and the consolidated results of operations of Borrower and its consolidated Subsidiaries. Since December 31, 20202013, there has not been a Material Adverse Change.
Appears in 1 contract
No Material Adverse Change; Financial Statements. All consolidated financial statements for Borrower and its consolidated Subsidiaries, delivered to Collateral Agent fairly present, in conformity with GAAP, and in all material respects the consolidated financial condition of Borrower and its consolidated Subsidiaries, and the consolidated results of operations of Borrower and its consolidated Subsidiaries. Since December 31, 20202019, there has not been a Material Adverse Change.
Appears in 1 contract
No Material Adverse Change; Financial Statements. All consolidated financial statements for Borrower and its consolidated Subsidiaries, delivered to Collateral Agent fairly present, in conformity with GAAPapplicable law and IFRS, and in all material respects the consolidated financial condition of Borrower and its consolidated Subsidiaries, and the consolidated results of operations of Borrower and its consolidated Subsidiaries. Since December 31, 2020the date of the most recent financial statements submitted to any Lender, there has not been a Material Adverse Change.
Appears in 1 contract
No Material Adverse Change; Financial Statements. All consolidated financial statements for Borrower and its consolidated Subsidiaries, delivered to Collateral Agent fairly present, in conformity with GAAP, and in all material respects the consolidated financial condition of Borrower and its consolidated Subsidiaries, and the consolidated results of operations of Borrower and its consolidated Subsidiaries. Since December 31, 20202013, there has not been a Material Adverse Change.
Appears in 1 contract
No Material Adverse Change; Financial Statements. All consolidated financial statements for Borrower the Loan Parties and its their consolidated Subsidiaries, delivered to Collateral Agent fairly present, in conformity with GAAP, and in all material respects the consolidated financial condition of Borrower the Loan Parties and its their consolidated Subsidiaries, and the consolidated results of operations of Borrower the Loan Parties and its their consolidated Subsidiaries. Since December 31, 20202017, there has not been a Material Adverse Change.
Appears in 1 contract
Samples: Loan and Security Agreement (Apollo Endosurgery, Inc.)
No Material Adverse Change; Financial Statements. All consolidated financial statements for Borrower and its consolidated Subsidiaries, delivered to Collateral Agent fairly present, in conformity with GAAP, and in all material respects the consolidated financial condition of Borrower and its consolidated Subsidiaries, and the consolidated results of operations of Borrower and its consolidated SubsidiariesSubsidiaries as of and for the dates presented. Since December 31, 20202018, there has not been a Material Adverse Change.
Appears in 1 contract
Samples: Loan and Security Agreement (Senseonics Holdings, Inc.)
No Material Adverse Change; Financial Statements. All consolidated financial statements for Borrower and its consolidated Subsidiaries, delivered to Collateral Agent fairly present, in conformity with GAAP, and in all material respects the consolidated financial condition of Borrower and its consolidated Subsidiaries, and the consolidated results of operations of Borrower and its consolidated Subsidiaries. Since December 31, 20202014, there has not been a Material Adverse Change.
Appears in 1 contract
No Material Adverse Change; Financial Statements. All consolidated financial statements for Borrower and its consolidated Subsidiaries, delivered to Collateral Agent fairly present, in conformity with GAAP, and in all material respects the consolidated financial condition of Borrower and its consolidated Subsidiaries, and the consolidated results of operations of Borrower and its consolidated SubsidiariesSubsidiaries as of and for the dates presented. Since December 31, 20202015, there has not been a Material Adverse Change.
Appears in 1 contract
No Material Adverse Change; Financial Statements. All consolidated financial statements for Borrower and its consolidated Subsidiaries, delivered to Collateral Agent Lender fairly present, in conformity with GAAP, and in all material respects the consolidated financial condition of Borrower and its consolidated Subsidiaries, and the consolidated results of operations of Borrower and its consolidated Subsidiaries. Since December 31, 20202017, there has not been a Material Adverse Change.
Appears in 1 contract
No Material Adverse Change; Financial Statements. All consolidated financial statements for Borrower and its consolidated Subsidiaries, delivered to Collateral Agent fairly present, in conformity with GAAP, and in all material respects the consolidated financial condition of Borrower and its consolidated Subsidiaries, and the consolidated results of operations of Borrower and its consolidated Subsidiaries. Since December 31, 20202016, there has not been a Material Adverse Change.
Appears in 1 contract
Samples: Loan and Security Agreement (Imprimis Pharmaceuticals, Inc.)
No Material Adverse Change; Financial Statements. All consolidated financial statements for Borrower and its consolidated Subsidiaries, delivered to Collateral Agent fairly present, in conformity with GAAP, except for the absence of footnotes and subject to year end adjustments for unaudited financial statements, in all material respects the consolidated financial condition of Borrower and its consolidated Subsidiaries, and the consolidated results of operations of Borrower and its consolidated Subsidiaries. Since December 31, 20202017, there has not been a Material Adverse Change.
Appears in 1 contract
Samples: Loan and Security Agreement (Tetraphase Pharmaceuticals Inc)
No Material Adverse Change; Financial Statements. All consolidated financial statements for Borrower and its consolidated Subsidiaries, delivered to Collateral Agent fairly present, in conformity with GAAP, and in all material respects the consolidated financial condition of Borrower and its consolidated Subsidiaries, and the consolidated results of operations of Borrower and its consolidated Subsidiaries. Since December 31, 2020the date of the most recent financial statements submitted as required by this Agreement, there has not been a Material Adverse Change.
Appears in 1 contract
No Material Adverse Change; Financial Statements. All consolidated financial statements for the Borrower and its consolidated Subsidiaries, delivered to Collateral Agent fairly present, in conformity with GAAP, and in all material respects respects, the consolidated financial condition of the Borrower and its consolidated Subsidiaries, and the consolidated results of operations of the Borrower and its consolidated Subsidiaries. Since December 31, 20202013, there has not been a Material Adverse Change.
Appears in 1 contract
Samples: Loan and Security Agreement (Global Eagle Entertainment Inc.)
No Material Adverse Change; Financial Statements. All consolidated financial statements for Borrower and its consolidated Subsidiaries, delivered to Collateral Agent fairly present, in conformity with GAAP, and in all material respects the consolidated financial condition of Borrower and its consolidated Subsidiaries, and the consolidated results of operations of Borrower and its consolidated Subsidiaries. Since December 31, 2020the date of the most recent financial statements submitted to Collateral Agent, there has not been a Material Adverse Change.
Appears in 1 contract
